Filing Details

Accession Number:
0000711377-15-000004
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-03-31 12:35:30
Reporting Period:
2015-03-30
Filing Date:
2015-03-31
Accepted Time:
2015-03-31 12:35:30
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
711377 Neogen Corp NEOG In Vitro & In Vivo Diagnostic Substances (2835) 382367843
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1189021 Edward Bradley Vice President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-03-30 24,300 $5.45 206,830 No 4 M Direct
Common Stock Disposition 2015-03-30 24,300 $47.02 182,530 No 4 S Direct
Common Stock Acquisiton 2015-03-30 20,072 $18.68 202,602 No 4 M Direct
Common Stock Disposition 2015-03-30 20,072 $47.02 182,530 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock (Right to Buy) Disposition 2015-03-30 24,300 $0.00 24,300 $5.45
Common Stock Common Stock (Right to Buy) Disposition 2015-03-30 20,072 $0.00 20,072 $18.68
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
134,238 2015-10-31 No 4 M Direct
114,166 2015-08-24 No 4 M Direct
Footnotes
  1. Options were granted 10/31/2005, have ten year lives and were fully vested in 2010
  2. Options were granted 8/24/2011, have a five year life, and vest 20% annually on the anniversary date of the grant